PrimeRFP SCOUT · Federal Contract Recompete Brief

75D30120F09836ME CFS myalgic encephalomyelitis chronic fatigue — Webmd Health Corp

Webmd Health Corp holds $7.0M across 33 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 2 related awards under parent GS02F0034W. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Mar 23, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Cdc Office Of Acquisition Services

Awarding office

Webmd Health Corp

Recipient

Mar 23, 2022

PoP end

$-0.2

Obligated

$250K

Potential

611430

NAICS

R499

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Webmd Health Corp — $90

Contract facts

Federal

Contract number75D30120F09836

Also listed asGS02F0034W-75D30120F09836

AgencyCdc Office Of Acquisition Services

Awarding officeCdc Office Of Acquisition Services

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentWebmd Health Corp

CAGE4PTZ0

UEILJ8EVFE8SB55

NAICS611430

No full NAICS 611430 intel page yet. Browse NAICS intelligence

PSCR499

Parent IDIQ / IDVGS02F0034W

Place of performanceNEW YORK NY

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

Related solicitation75D301-20-Q-72132

PoP startSep 24, 2020

PoP end (current)Mar 23, 2022

Obligated$-0.2

Current value$250K

Potential value$250K

MYALGIC ENCEPHALOMYELITIS (ME)/CHRONIC FATIGUE SYNDROME (CFS) OUTLINE is a federal award for Cdc Office Of Acquisition Services held by Webmd Health Corp. Estimated value $250K ($-0.2 obligated). Current period of performance ends Mar 23, 2022. Last award drew 1 bidder. Place of performance: NEW YORK NY. Related solicitation 75D301-20-Q-72132.

MYALGIC ENCEPHALOMYELITIS (ME)/CHRONIC FATIGUE SYNDROME (CFS) OUTLINE

Recompete timing

Public

● Past PoP end (1612 days ago)

Current PoP ended Mar 23, 2022 (1612 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Webmd Health Corp — $7.0M obligated across 33 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$6.8M · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

75D30125F20649

TECHNICAL SERVICES - SPOLIGHT COURSES

$214K

Sep 25, 2027

75P00124F80197

ACCREDITED CONTINUING PROFESSIONAL EDUCATION SERVICES FOR HEALTHCARE PROVIDERS ON WOMEN'S …

$3.2M

Sep 29, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75D30120F09836?

75D30120F09836 (ME CFS myalgic encephalomyelitis chronic fatigue) is a Cdc Office Of Acquisition Services award with a potential value of $250K, currently held by Webmd Health Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75D30120F09836?

Cdc Office Of Acquisition Services awarded 75D30120F09836 to Webmd Health Corp (potential $250K).

Who is the incumbent on 75D30120F09836?

Webmd Health Corp is the incumbent with $7.0M across 33 related awards in SCOUT’s public footprint. The current period of performance ends Mar 23, 2022.

When does Webmd Health Corp’s 75D30120F09836 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 23, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Mar 30, 2024